These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 31307011)

  • 21. Metformin: a metabolic disruptor and anti-diabetic drug to target human leukemia.
    Rosilio C; Ben-Sahra I; Bost F; Peyron JF
    Cancer Lett; 2014 May; 346(2):188-96. PubMed ID: 24462823
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment with metformin is associated with higher remission rate in diabetic patients with thyroid cancer.
    Klubo-Gwiezdzinska J; Costello J; Patel A; Bauer A; Jensen K; Mete M; Burman KD; Wartofsky L; Vasko V
    J Clin Endocrinol Metab; 2013 Aug; 98(8):3269-79. PubMed ID: 23709654
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metformin use and gynecological cancers: A novel treatment option emerging from drug repositioning.
    Gadducci A; Biglia N; Tana R; Cosio S; Gallo M
    Crit Rev Oncol Hematol; 2016 Sep; 105():73-83. PubMed ID: 27378194
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Metformin, an antidiabetic molecule with anti-cancer properties].
    Beck E; Scheen AJ
    Rev Med Liege; 2013 Sep; 68(9):444-9. PubMed ID: 24180199
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metformin in Oncology - How Far Is Its Repurposing as an Anticancer Drug?
    Pácal L; Kaňková K
    Klin Onkol; 2020; 33(2):107-113. PubMed ID: 32303131
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changes in protein expression due to metformin treatment and hyperinsulinemia in a human endometrial cancer cell line.
    Lange C; Machado Weber A; Schmidt R; Schroeder C; Strowitzki T; Germeyer A
    PLoS One; 2021; 16(3):e0248103. PubMed ID: 33690729
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [New perspectives for metformin in cancer therapy].
    Loubière C; Dirat B; Tanti JF; Bost F
    Ann Endocrinol (Paris); 2013 May; 74(2):130-6. PubMed ID: 23587351
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metformin with everolimus and octreotide in pancreatic neuroendocrine tumor patients with diabetes.
    Pusceddu S; Buzzoni R; Vernieri C; Concas L; Marceglia S; Giacomelli L; Milione M; Leuzzi L; Femia D; Formisano B; Mazzaferro V; de Braud F
    Future Oncol; 2016 May; 12(10):1251-60. PubMed ID: 26890290
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metformin and Anti-Cancer Therapeutics: Hopes for a More Enhanced Armamentarium Against Human Neoplasias?
    Christodoulou MI; Scorilas A
    Curr Med Chem; 2017; 24(1):14-56. PubMed ID: 27604091
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Autophagy-dependent and -independent modulation of oxidative and organellar stress in the diabetic heart by glucose-lowering drugs.
    Packer M
    Cardiovasc Diabetol; 2020 May; 19(1):62. PubMed ID: 32404204
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [New clinical data with metformin therapy in patients with diabetes mellitus].
    Jermendy G
    Orv Hetil; 2010 Dec; 151(49):2025-30. PubMed ID: 21106483
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metformin and longevity (METAL): a window of opportunity study investigating the biological effects of metformin in localised prostate cancer.
    Crawley D; Chandra A; Loda M; Gillett C; Cathcart P; Challacombe B; Cook G; Cahill D; Santa Olalla A; Cahill F; George G; Rudman S; Van Hemelrijck M
    BMC Cancer; 2017 Jul; 17(1):494. PubMed ID: 28732480
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metformin in prostate cancer: two for the price of one.
    Clements A; Gao B; Yeap SHO; Wong MKY; Ali SS; Gurney H
    Ann Oncol; 2011 Dec; 22(12):2556-2560. PubMed ID: 21421541
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metformin: multi-faceted protection against cancer.
    Del Barco S; Vazquez-Martin A; Cufí S; Oliveras-Ferraros C; Bosch-Barrera J; Joven J; Martin-Castillo B; Menendez JA
    Oncotarget; 2011 Dec; 2(12):896-917. PubMed ID: 22203527
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of midkine by metformin can contribute to its anticancer effects in malignancies: A proposal mechanism of action of metformin in context of endometrial cancer prevention and therapy.
    Karadeniz Z; Aynacıoğlu AŞ; Bilir A; Tuna MY
    Med Hypotheses; 2020 Jan; 134():109420. PubMed ID: 31634770
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metformin as an anti-cancer agent: actions and mechanisms targeting cancer stem cells.
    Saini N; Yang X
    Acta Biochim Biophys Sin (Shanghai); 2018 Feb; 50(2):133-143. PubMed ID: 29342230
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metformin disrupts crosstalk between G protein-coupled receptor and insulin receptor signaling systems and inhibits pancreatic cancer growth.
    Kisfalvi K; Eibl G; Sinnett-Smith J; Rozengurt E
    Cancer Res; 2009 Aug; 69(16):6539-45. PubMed ID: 19679549
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-Inflammatory Effects of Metformin Irrespective of Diabetes Status.
    Cameron AR; Morrison VL; Levin D; Mohan M; Forteath C; Beall C; McNeilly AD; Balfour DJ; Savinko T; Wong AK; Viollet B; Sakamoto K; Fagerholm SC; Foretz M; Lang CC; Rena G
    Circ Res; 2016 Aug; 119(5):652-65. PubMed ID: 27418629
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protective effects of metformin in various cardiovascular diseases: Clinical evidence and AMPK-dependent mechanisms.
    Bu Y; Peng M; Tang X; Xu X; Wu Y; Chen AF; Yang X
    J Cell Mol Med; 2022 Oct; 26(19):4886-4903. PubMed ID: 36052760
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metformin and Its Benefits for Various Diseases.
    Lv Z; Guo Y
    Front Endocrinol (Lausanne); 2020; 11():191. PubMed ID: 32425881
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.